1
Country: Israel | Funding: $265.2M
Lifeward produces robotic devices for people with physical limitations or disabilities. Its ReWalk personal exoskeleton allows paralyzed people to access the benefits of walking. ReStore exosuit - universal robotic gait training solution designed to restore functional walking patterns after stroke. MYOLYN FES exercise bike allows people with weakened or paralyzed legs to engage in therapeutic cycling in the clinic or at home. AlterG antigravity system - innovative treadmill with a compressed air chamber to reduce gravitational load, allowing people to move in new and pain-free ways to improve mobility, well-being, and physical performance.
Lifeward produces robotic devices for people with physical limitations or disabilities. Its ReWalk personal exoskeleton allows paralyzed people to access the benefits of walking. ReStore exosuit - universal robotic gait training solution designed to restore functional walking patterns after stroke. MYOLYN FES exercise bike allows people with weakened or paralyzed legs to engage in therapeutic cycling in the clinic or at home. AlterG antigravity system - innovative treadmill with a compressed air chamber to reduce gravitational load, allowing people to move in new and pain-free ways to improve mobility, well-being, and physical performance.
2
Country: USA | Funding: $183M
Sudo Biosciences is a biopharmaceutical company committed to developing cutting-edge medications that are unmatched in their class that advances programs in multiple sclerosis and psoriasis
Sudo Biosciences is a biopharmaceutical company committed to developing cutting-edge medications that are unmatched in their class that advances programs in multiple sclerosis and psoriasis
3
Country: USA | Funding: $142.1M
Octave is a biotechnology company that uses precision medicine and scientific insights to treat patients with multiple sclerosis.
Octave is a biotechnology company that uses precision medicine and scientific insights to treat patients with multiple sclerosis.
4
Country: USA | Funding: $135.5M
The Cour particle platforms provide a novel and highly specific immune targeting capability which may be safely applied to severe inflammatory modulation, and immune (antigen) tolerization.
The Cour particle platforms provide a novel and highly specific immune targeting capability which may be safely applied to severe inflammatory modulation, and immune (antigen) tolerization.
5
Country: Switzerland | Funding: $54.6M
GeNeuro develops innovative treatments against inflammatory and degenerative disorders associated with endogenous retroviruses.
GeNeuro develops innovative treatments against inflammatory and degenerative disorders associated with endogenous retroviruses.
6
Country: Denmark | Funding: $38M
Dawn Health is a digital health company specializing in developing regulated software-as-a-medical-device and digital therapeutics, used in oncology and for multiple sclerosis and rare pediatric conditions, like growth disorders
Dawn Health is a digital health company specializing in developing regulated software-as-a-medical-device and digital therapeutics, used in oncology and for multiple sclerosis and rare pediatric conditions, like growth disorders
7
Country: USA | Funding: $15.7M
28bio's Nerve-on-a-Chip platform facilitates prediction of both clinical neurotoxicity and efficacy in human neurodegenerative disease models earlier in the drug development pipeline.
28bio's Nerve-on-a-Chip platform facilitates prediction of both clinical neurotoxicity and efficacy in human neurodegenerative disease models earlier in the drug development pipeline.
8
Country: Spain | Funding: €5.1M
Bionure Farma develops innovative therapies for the treatment of orphan ophthalmology diseases and multiple sclerosis.
Bionure Farma develops innovative therapies for the treatment of orphan ophthalmology diseases and multiple sclerosis.
9
Country: Switzerland | Funding: 3
ReHaptix is a clinically validated mHealth application assisting patients and healthcare professionals in monitoring the rehabilitation progress of patients suffering from upper limb impairments caused by a neurological injury, such as stroke, multiple sclerosis or Parkinson's disease.
ReHaptix is a clinically validated mHealth application assisting patients and healthcare professionals in monitoring the rehabilitation progress of patients suffering from upper limb impairments caused by a neurological injury, such as stroke, multiple sclerosis or Parkinson's disease.
10
Country: Russia
Innovative startup for the analysis and diagnosis of multiple sclerosis. Provides cloud service for analyzing MS lesions powered by artificial intelligence
Innovative startup for the analysis and diagnosis of multiple sclerosis. Provides cloud service for analyzing MS lesions powered by artificial intelligence
